BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32756013)

  • 1. Rapamycin for aging stem cells.
    Hambright WS; Philippon MJ; Huard J
    Aging (Albany NY); 2020 Aug; 12(15):15184-15185. PubMed ID: 32756013
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapamycin increases oxidative stress response gene expression in adult stem cells.
    Kofman AE; McGraw MR; Payne CJ
    Aging (Albany NY); 2012 Apr; 4(4):279-89. PubMed ID: 22529334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From rapalogs to anti-aging formula.
    Blagosklonny MV
    Oncotarget; 2017 May; 8(22):35492-35507. PubMed ID: 28548953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin, proliferation and geroconversion to senescence.
    Blagosklonny MV
    Cell Cycle; 2018; 17(24):2655-2665. PubMed ID: 30541374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin and the inhibition of the secretory phenotype.
    Wang R; Sunchu B; Perez VI
    Exp Gerontol; 2017 Aug; 94():89-92. PubMed ID: 28167236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.
    Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI
    Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging, stem cells, and mammalian target of rapamycin: a prospect of pharmacologic rejuvenation of aging stem cells.
    Blagosklonny MV
    Rejuvenation Res; 2008 Aug; 11(4):801-8. PubMed ID: 18729812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapalogs in cancer prevention: anti-aging or anticancer?
    Blagosklonny MV
    Cancer Biol Ther; 2012 Dec; 13(14):1349-54. PubMed ID: 23151465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual response to mTOR inhibition in delaying replicative senescence of mesenchymal stromal cells.
    Antonioli E; Torres N; Ferretti M; Piccinato CA; Sertie AL
    PLoS One; 2019; 14(1):e0204784. PubMed ID: 30703123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging-suppressants: cellular senescence (hyperactivation) and its pharmacologic deceleration.
    Blagosklonny MV
    Cell Cycle; 2009 Jun; 8(12):1883-7. PubMed ID: 19448395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gerosuppression by pan-mTOR inhibitors.
    Leontieva OV; Blagosklonny MV
    Aging (Albany NY); 2016 Dec; 8(12):3535-3551. PubMed ID: 28077803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis.
    Iglesias-Bartolome R; Patel V; Cotrim A; Leelahavanichkul K; Molinolo AA; Mitchell JB; Gutkind JS
    Cell Stem Cell; 2012 Sep; 11(3):401-14. PubMed ID: 22958932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new trick for an old drug: mTOR inhibitor rapamycin augments the effect of fluorouracil on hepatocellular carcinoma by inducing cell senescence.
    Shi Y; August DA
    Cancer Biol Ther; 2008 Mar; 7(3):397-8. PubMed ID: 18344684
    [No Abstract]   [Full Text] [Related]  

  • 14. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition.
    Blagosklonny MV
    Cell Cycle; 2006 Sep; 5(18):2087-102. PubMed ID: 17012837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin preserves gut homeostasis during Drosophila aging.
    Fan X; Liang Q; Lian T; Wu Q; Gaur U; Li D; Yang D; Mao X; Jin Z; Li Y; Yang M
    Oncotarget; 2015 Nov; 6(34):35274-83. PubMed ID: 26431326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forever young, slim and fit: rapamycin to the rescue.
    Darzynkiewicz Z
    Cell Cycle; 2009 Jun; 8(12):1820-1. PubMed ID: 19471126
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelial replicative senescence delayed by the inhibition of MTORC1 signaling involves MicroRNA-107.
    Khor ES; Wong PF
    Int J Biochem Cell Biol; 2018 Aug; 101():64-73. PubMed ID: 29857052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M(o)TOR of pseudo-hypoxic state in aging: rapamycin to the rescue.
    Leontieva OV; Blagosklonny MV
    Cell Cycle; 2014; 13(4):509-15. PubMed ID: 24496328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence.
    Demidenko ZN; Shtutman M; Blagosklonny MV
    Cell Cycle; 2009 Jun; 8(12):1896-900. PubMed ID: 19478560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin prevents the intervertebral disc degeneration via inhibiting differentiation and senescence of annulus fibrosus cells.
    Gao C; Ning B; Sang C; Zhang Y
    Aging (Albany NY); 2018 Jan; 10(1):131-143. PubMed ID: 29348392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.